Who
Craig Tendler
Director
Company insider
Files Form 4 as: Director, Parabilis Medicines; Director, TuHURA Biosciences.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Mar 2025
- Last trade
- 22 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Aug 2026filed 25 Aug 2026 | PBLS Parabilis Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,294 at $0.00 | filing |
| 22 Aug 2026filed 25 Aug 2026 | PBLS Parabilis Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,294 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —156,240 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —156,240 at $0.00 | filing |
| 10 Mar 2025filed 19 Mar 2025 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —151,883 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.